Opus Genetics, Inc. · NASDAQ:IRD
BIOS ADVISORS GP, LLC's stake in Opus Genetics, Inc. fell to 4.53% (Schedule 13G/A)
Event May 12, 2026 · Filed May 13, 2026
BIOS ADVISORS GP, LLC's stake in Opus Genetics, Inc. fell to 4.53%, 3,683,429 shares, as a passive investor on May 12, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 4.53%
- Shares
- 3,683,429
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AARON G.L. FLETCHER | 4.53% | 3,683,429 |
| BIOS ADVISORS GP, LLC | 4.53% | 3,683,429 |
| BIOS CAPITAL MANAGEMENT, LP | 4.53% | 3,683,429 |
| BIOS EQUITY PARTNERS III, LP | 4.53% | 3,683,429 |
| BIOS FUND III, LP | 0.53% | 430,665 |
| BIOS FUND III NT, LP | 0.55% | 450,811 |
| BIOS FUND III QP, LP | 3.44% | 2,801,953 |
| CAVU ADVISORS, LLC | 4.53% | 3,683,429 |
| CAVU MANAGEMENT, LP | 4.53% | 3,683,429 |
| LESLIE W. KREIS | 4.53% | 3,683,429 |
Source
Related
- Opus Genetics, Inc.
- Bios Advisors Gp, LLC
- Opus Genetics, Inc. shareholders
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026